Literature DB >> 16156659

Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation.

Antony S Dimitrov1, John M Louis, Carole A Bewley, G Marius Clore, Robert Blumenthal.   

Abstract

HIV-1 envelope glycoprotein-mediated fusion is driven by the concerted coalescence of the HIV-1 gp41 N- and C-helical regions, which results in the formation of 6-helix bundles. These two regions are considered prime targets for peptides and antibodies that inhibit HIV-1 entry. However, the parameters that govern this inhibition have yet to be elucidated. We address this issue by monitoring the temporal sequence of conformational states of HIV-1 gp41 during the course of HIV-1-mediated cell-cell fusion by quantitative video microscopy using reagents that bind to N- and C-helical regions, respectively. Env-expressing cells were primed by incubation with target cells at different times at 37 degrees C followed by washing. The reactivity of triggered gp41 to the NC-1 monoclonal antibody, which we demonstrate here to bind to N-helical gp41 trimers, increased rapidly to a maximal level in the primed state but decreased once stable fusion junctions had formed. In contrast, reactivity with 5-helix, which binds to the C-helical region of gp41, increased continuously as a function of time following the priming. The peptide N36(Mut(e,g)) reduced NC-1 monoclonal antibody binding and enhanced 5-helix binding, consistent with the notion that this molecule promotes dissociation of gp41 trimers. This inactivation pathway may be important for the design of entry inhibitors and vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16156659      PMCID: PMC1314968          DOI: 10.1021/bi051092d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  45 in total

1.  Protein design of an HIV-1 entry inhibitor.

Authors:  M J Root; M S Kay; P S Kim
Journal:  Science       Date:  2001-02-02       Impact factor: 47.728

Review 2.  Structural basis for membrane fusion by enveloped viruses.

Authors:  W Weissenhorn; A Dessen; L J Calder; S C Harrison; J J Skehel; D C Wiley
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

3.  Steric accessibility of the HIV-1 gp41 N-trimer region.

Authors:  Agnes E Hamburger; Sunghwan Kim; Brett D Welch; Michael S Kay
Journal:  J Biol Chem       Date:  2005-01-18       Impact factor: 5.157

4.  Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target.

Authors:  D C Chan; C T Chutkowski; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  Design and properties of N(CCG)-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity.

Authors:  J M Louis; C A Bewley; G M Clore
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

6.  Monomer-trimer equilibrium of the ectodomain of SIV gp41: insight into the mechanism of peptide inhibition of HIV infection.

Authors:  M Caffrey; J Kaufman; S Stahl; P Wingfield; A M Gronenborn; G M Clore
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

7.  Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.

Authors:  Elena Gustchina; Gerhard Hummer; Carole A Bewley; G Marius Clore
Journal:  J Med Chem       Date:  2005-04-21       Impact factor: 7.446

8.  Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41.

Authors:  M K Gorny; S Zolla-Pazner
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  HIV-1 membrane fusion: targets of opportunity.

Authors:  R W Doms; J P Moore
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

10.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

View more
  30 in total

1.  Fab crystallization and preliminary X-ray analysis of NC-1, an anti-HIV-1 antibody that recognizes the six-helix bundle core of gp41.

Authors:  Lei Jin; Chungen Pan; Zhi Qi; Z Hong Zhou; Shibo Jiang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-06-24

2.  The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation.

Authors:  Jing-He Huang; Heng-Wen Yang; Shuwen Liu; Jing Li; Shibo Jiang; Ying-Hua Chen
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

Review 3.  The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Authors:  Marinieve Montero; Nienke E van Houten; Xin Wang; Jamie K Scott
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 11.056

4.  Immunization with hybrid proteins containing the membrane proximal external region of HIV-1.

Authors:  Nicola Strasz; Vladimir A Morozov; Jürgen Kreutzberger; Martina Keller; Magdalena Eschricht; Joachim Denner
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-07       Impact factor: 2.205

5.  Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer.

Authors:  Youdong Mao; Liping Wang; Christopher Gu; Alon Herschhorn; Anik Désormeaux; Andrés Finzi; Shi-Hua Xiang; Joseph G Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-11       Impact factor: 11.205

6.  Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41.

Authors:  Donna L Montgomery; Ying-Jie Wang; Renee Hrin; Micah Luftig; Bin Su; Michael D Miller; Fubao Wang; Peter Haytko; Lingyi Huang; Salvatore Vitelli; Jon Condra; Xiaomei Liu; Richard Hampton; Andrea Carfi; Antonello Pessi; Elisabetta Bianchi; Joseph Joyce; Chris Lloyd; Romas Geleziunas; David Bramhill; Vicki M King; Adam C Finnefrock; William Strohl; Zhiqiang An
Journal:  MAbs       Date:  2009-09-08       Impact factor: 5.857

7.  Designing a soluble near full-length HIV-1 gp41 trimer.

Authors:  Guofen Gao; Lindsay Wieczorek; Kristina K Peachman; Victoria R Polonis; Carl R Alving; Mangala Rao; Venigalla B Rao
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

8.  The M-T hook structure is critical for design of HIV-1 fusion inhibitors.

Authors:  Huihui Chong; Xue Yao; Jianping Sun; Zonglin Qiu; Meng Zhang; Sandro Waltersperger; Meitian Wang; Sheng Cui; Yuxian He
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

9.  Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41.

Authors:  Elena Gustchina; Carole A Bewley; G Marius Clore
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

10.  Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations.

Authors:  Kelly Sackett; Matthew J Nethercott; Raquel F Epand; Richard M Epand; Douglas R Kindra; Yechiel Shai; David P Weliky
Journal:  J Mol Biol       Date:  2010-01-18       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.